Shares of Aequus Pharmaceuticals Inc. (CVE:AQS – Get Free Report) reached a new 52-week low during trading on Wednesday . The stock traded as low as C$0.01 and last traded at C$0.01, with a volume of 100000 shares trading hands. The stock had previously closed at C$0.01.
Aequus Pharmaceuticals Stock Up 100.0 %
The business’s 50 day simple moving average is C$0.01 and its 200 day simple moving average is C$0.01. The company has a current ratio of 0.07, a quick ratio of 0.46 and a debt-to-equity ratio of 138.88. The firm has a market capitalization of C$1.33 million, a PE ratio of -1.00 and a beta of -0.02.
About Aequus Pharmaceuticals
Aequus Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease.
Featured Articles
- Five stocks we like better than Aequus Pharmaceuticals
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Are Penny Stocks a Good Fit for Your Portfolio?
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Consumer Discretionary Stocks Explained
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Aequus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aequus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
